Evidence map›Paper›PMID 42683143›Full record

ArticleERJ open research2026

Outcomes of transition from selexipag to parenteral prostacyclin analogues in patients with pulmonary arterial hypertension.

Ebrahim AlEissa, Lisa Kolkman, Ali Kapasi, Defen Peng, Steeve Provencher, Nathan Brunner, John Swiston

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ebrahim AlEissaDepartment of Medicine, Division of Respiratory Medicine, The University of British Columbia, Vancouver, BC, Canada.ORCID https://orcid.org/0009-0009-4904-1405
Lisa KolkmanDepartment of Medicine, Division of Respiratory Medicine, The University of British Columbia, Vancouver, BC, Canada.ORCID https://orcid.org/0000-0003-0850-4513
Ali KapasiDepartment of Medicine, Division of Respiratory Medicine, The University of British Columbia, Vancouver, BC, Canada.
Defen PengCentre for Cardiovascular Innovation, The University of British Columbia, Vancouver, BC, Canada.
Steeve ProvencherInstitut Universitaire de Cardiologie et de Pneumologie de Québec Research Center, Université Laval, Québec City, QC, Canada.
Nathan BrunnerDepartment of Medicine, Division of Cardiology, The University of British Columbia, Vancouver, BC, Canada.
John SwistonDepartment of Medicine, Division of Respiratory Medicine, The University of British Columbia, Vancouver, BC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42683143
PMCPMC13531287

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.